1. Kuriyama M, Fujiyama J, Kasama T, Osame M. High levels of plant sterols and cholesterol precursors in cerebrotendinous xanthomatosis. J Lipid Res. 1991; 32:223–229. PMID:
2066659.
2. Yoo EG. Sitosterolemia: a review and update of pathophysiology, clinical spectrum, diagnosis, and management. Ann Pediatr Endocrinol Metab. 2016; 21:7–14. PMID:
27104173.
3. Kidambi S, Patel SB. Sitosterolaemia: pathophysiology, clinical presentation and laboratory diagnosis. J Clin Pathol. 2008; 61:588–594. PMID:
18441155.
4. Escola-Gil JC, Quesada H, Julve J, Martin-Campos JM, Cedo L, Blanco-Vaca F. Sitosterolemia: diagnosis, investigation, and management. Curr Atheroscler Rep. 2014; 16:424. PMID:
24821603.
5. CSLI. CLSI document EP06-A. Evaluation of the linearity of quantitative measurement procedures: a statistical approach; approved guideline. Wayne, PA: Clinical and Laboratory Standards Institute;2003.
6. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem. 2003; 75:3019–3030. PMID:
12964746.
7. Lorincz MT, Rainier S, Thomas D, Fink JK. Cerebrotendinous xanthomatosis: possible higher prevalence than previously recognized. Arch Neurol. 2005; 62:1459–1463. PMID:
16157755.
8. Patel SB. Sitosterolemia and other rare sterol disorders. In : Garg A, editor. Dyslipidemias: pathophysiology, evaluation and management. 1st ed. New York: Humana Press;2015. p. 235–250.
9. Lee MH, Lu K, Patel SB. Genetic basis of sitosterolemia. Curr Opin Lipidol. 2001; 12:141–149. PMID:
11264985.
10. Park JH, Chung IH, Kim DH, Choi MH, Garg A, Yoo EG. Sitosterolemia presenting with severe hypercholesterolemia and intertriginous xanthomas in a breastfed infant: case report and brief review. J Clin Endocrinol Metab. 2014; 99:1512–1518. PMID:
24423340.